UK - Wellcome Trust invests £3.5m in Novacta Biosystems
The Wellcome Trust has provided Novacta Biosystems, an anti-infective therapeutics company, with a £3.5m award and investment. The deal sees medical research charity Wellcome take a minority stake in the business which previously received £900,000 of funding from the Rainbow Seed Fund and Oxford Technology 4 VCT in 2005.
More on Early-stage
Gorillas raises circa USD 1bn in Delivery Hero-led Series C
New funding comes just seven months after a Series B, with the company doubling in value
French mega-rounds shoot up in 2021
France has already seen as many rounds of EUR 100m and above than in 2019 and 2020 combined, Unquote Data shows
L Catterton et al. in EUR 100m round for SellerX
SellerX has already raised amost EUR 250m in debt and equity in its 12 months since inception
Mega-rounds fuel record H1 for venture and growth
Largest rounds inked in the first six months of 2021 read like a veritable Who's Who of European fintech heavyweights
Latest News
Raise heads for second close for debut impact VC fund
French sponsor seeks to attract state-backed LPs for new strategy targeting ESG-focused startups
Graphite makes value creation and investment team hires
Director appointments include Rutland Partners' Matt Hamilton-Allen, who joins the investment team
Pantheon closes private debt secondary fund on USD 834m
New vehicle exceeded target by more than USD 300m; aims for up to 20% exposure to European debt
Cathay Capital launches EUR 500m health fund
New vehicle will invest at the crossover of health care, life sciences and tech with EUR 5m-50m tickets